chr6-108323852-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145315.5(AFG1L):c.167T>A(p.Met56Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000644 in 1,614,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M56V) has been classified as Likely benign.
Frequency
Consequence
NM_145315.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AFG1L | NM_145315.5 | c.167T>A | p.Met56Lys | missense_variant | 2/13 | ENST00000368977.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AFG1L | ENST00000368977.9 | c.167T>A | p.Met56Lys | missense_variant | 2/13 | 1 | NM_145315.5 | P1 | |
AFG1L | ENST00000437715.1 | c.68T>A | p.Met23Lys | missense_variant | 3/6 | 5 | |||
AFG1L | ENST00000421954.5 | c.18+28634T>A | intron_variant | 5 | |||||
AFG1L | ENST00000430458.1 | n.256T>A | non_coding_transcript_exon_variant | 2/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251466Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135908
GnomAD4 exome AF: 0.0000636 AC: 93AN: 1461850Hom.: 0 Cov.: 31 AF XY: 0.0000660 AC XY: 48AN XY: 727238
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 17, 2022 | The c.167T>A (p.M56K) alteration is located in exon 2 (coding exon 2) of the LACE1 gene. This alteration results from a T to A substitution at nucleotide position 167, causing the methionine (M) at amino acid position 56 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at